ISSN 2050-0904
9 papers in the library · 89 citations · publishing 2021-2024
Clinical Case Reports September 1, 2024 David S Jevotovsky, Harman Chopra, Court Wing et al. 9 citations
Key Clinical Message Psilocybin shows promise as a treatment for CRPS, offering significant pain relief and functional improvement in a patient with refractory symptoms. This case highlights the need for further research into psilocybin's efficacy and optimal dosing for chronic pain management.
Clinical Case Reports September 1, 2024 Swotantra Gautam, Aakash Neupane, Ivonne De La Hoz Molina et al. 1 citation
MDMA and cocaine can result in acute onset rhabdomyolysis. However, delayed onset rhabdomyolysis and its pathophysiology is of concern Early therapeutic intervention improves prognosis. Such cases should be promptly referred and managed in centers equipped with critical care and renal replacement therapy.
Clinical Case Reports August 30, 2024 Seragnoli Federico, Martignoni Geo, Martignoni Entela et al. 3 citations
Key Clinical Message This case study describes the feasibility and safety of psychedelic‐assisted therapy (PAT) as a home‐based intervention for a patient with throat cancer experiencing significant existential distress. The patient tolerated the intervention well. This case supports the feasibility and safety of PAT for patients with life‐threatening conditions in a home setting. Abstract...
Clinical Case Reports June 1, 2024 Nava Raj Sharma, Arjun Basnet, Saral Lamichhane et al. 4 citations
Chronic ketamine use can lead to sphincter of oddi dysfunction (SOD), causing various hepatobiliary complications. Recognizing substance abuse history is vital for early detection. Timely intervention can prevent irreversible liver and pancreas damage. Ketamine is commonly abused as a recreational drug worldwide due to its ability to induce euphoria-like effects. Ketamine abuse is associated...
Clinical Case Reports May 28, 2024 Harman Chopra, Tim Furnish, Monica Verduzco-Gutierrez et al. 6 citations
Key Clinical Message Long‐COVID syndrome lacks effective holistic treatment options. We present a case of a 41‐year‐old fully vaccinated female with Long‐COVID syndrome who obtained significant symptomatic relief after self‐medicating with psilocybin and MDMA. Abstract Long‐COVID, a syndrome persisting after the acute phase of coronavirus disease 2019 (COVID‐19), lacks effective holistic...
Clinical Case Reports March 1, 2023 Bruno Pedraz-Petrozzi, Michael Deuschle, Maria Gilles
We admitted a 42-year-old patient with severe treatment-resistant depression and with psychiatric comorbidities. The patient attempted suicide 5 weeks after admission. Subsequently, we initiated dextromethorphan/bupropion based on prior evidence. As a result, the patient demonstrated an improvement in mood symptoms and a reduction in suicide risk, leading to her discharge.
Clinical Case Reports December 1, 2022 Adem T. Can, Daniel F. Hermens, Jim Lagopoulos 6 citations
Abstract Numerous studies have demonstrated that low‐dose subanesthetic intravenous ketamine infusion treatment leads to rapid improvement of treatment‐resistant depression. The following case report describes the use of a very low‐dose subcutaneous ketamine as a form of maintenance in a patient with severe treatment‐resistant depression using a retrospective chart review.
Clinical Case Reports November 27, 2021 Palash Kumar Bose, Debika Ray, Prodip Biswas et al. 8 citations
Abstract Lysergic acid diethylamide (LSD) is a potent hallucinogenic drug affecting the mood and perception of an individual. Although LSD‐induced self‐inflicted cut‐throat wounds and self‐harm injuries are extremely rarely reported behaviors, some reports are coming out in recent days that may complicate the depiction of scenarios in forensic psychiatry settings.
Clinical Case Reports April 4, 2021 Terry Schwartz, Mary Ellen Trunko, David Feifel et al. 52 citations
Abstract Severe and enduring eating disorders (EDs) have the highest mortality rate of all psychiatric illnesses (Arch Gen Psychiatry, 2011, 68 , 724), especially when comorbid with treatment‐resistant depression (TRD) (Psychiatr Res, 2016, 244 , 45). We report on four patients with enduring EDs and TRD treated with repeat ketamine over 12 + months, showing improvement in depression with only...